← Eichor
Condition: Radiation Nephropathy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Radiation Nephropathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

CAIX PET/ CT Guided Radiation Therapy in CcRCC.
NA · 1 location(s) · Peking University First Hospital · NCT07540260
Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
Phase N/A · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT04892849
Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradi
Phase 2 · 1 location(s) · St. Jude Children's Research Hospital · NCT04968990
Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metast
Phase 2 · 1 location(s) · Yale University · NCT04974671
SABR for Renal Tumors
NA · 1 location(s) · University Health Network, Toronto · NCT03747133
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectab
Phase 2 · 328 location(s) · NRG Oncology · NCT05327686
Kidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177
Phase N/A · 1 location(s) · Hannah Schaefer · NCT06720532
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT05830058
Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
Phase 1 · 1 location(s) · University of California, Los Angeles · NCT05525507
Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT04235777
SABR Combined With Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer
Phase N/A · 2 location(s) · Peking University First Hospital · NCT06583070
Abscopal Effect of Ultra-Hypofractionated Radiation Plus Immunotherapy in Metastatic Renal Cell Carcinoma
Phase N/A · 1 location(s) · Zhe Chen · NCT07240610
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME T
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT04693377
Impact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile Lesions
NA · 1 location(s) · Centre Georges Francois Leclerc · NCT05783908
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to
Phase 3 · 270 location(s) · NRG Oncology · NCT06500455
Partial Volume High-Dose Irradiation in Renal Cell Carcinoma for Intra-TUmoural Control ALongside Current Management
NA · 1 location(s) · Royal Marsden NHS Foundation Trust · NCT06995664
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
NA · 13 location(s) · European Organisation for Research and Treatment of Cancer - · NCT04498767
Prospective Observational Trial of Image-guided Ablative STereotactic bOdy Radiation Therapy for Primary kidNey Cancer:
Phase N/A · 2 location(s) · Istituto Clinico Humanitas · NCT07299357
Pencil Beam Scanning in Patients With Renal Tumors
EARLY_Phase 1 · 1 location(s) · Children's Hospital of Philadelphia · NCT03810651
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05837767
Ablative Radioembolization of Renal Cell Carcinoma Trial
Phase 2 · 1 location(s) · Derek W. Cool · NCT06642220
Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma
Phase 3 · 1 location(s) · Samsung Medical Center · NCT06467097
Stereotactic Magnetic Resonance Guided Radiation Therapy
NA · 2 location(s) · Dana-Farber Cancer Institute · NCT04115254
LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
Phase N/A · 4 location(s) · University of Sydney · NCT05184790
A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy
Phase 2 · 1 location(s) · Jinling Hospital, China · NCT06255223
Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT
NA · 1 location(s) · Sunnybrook Health Sciences Centre · NCT05023265
Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer
Phase 2 · 1 location(s) · University of Texas Southwestern Medical Center · NCT06601296
The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)
NA · 1 location(s) · 4th Military Clinical Hospital with Polyclinic, Poland · NCT06707532
Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.
Phase 4 · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06903312
Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study)
Phase 3 · 9 location(s) · Sun Yat-sen University · NCT06726421
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.